Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Neurocrine Biosciences
NBIX
$16.6B
| $273K | ﹤0.01% |
30,314
-80,912
| -73% | -$790K |
|
4602
Insulet
PODD
$9.79B
| $273K | ﹤0.01% |
7,357
+4,955
| +206% | +$183K |
|
|
EMBJ
4603
PUT
Embraer S.A. ADS
EMBJ
$13B
| $272K | ﹤0.01% |
8,500
-5,700
| -40% | -$181K |
|
4604
CALL
Nomura Holdings
NMR
$29.1B
| $272K | ﹤0.01% |
38,800
| – | – |
|
4605
Saic
SAIC
$5.35B
| $272K | ﹤0.01% |
+8,304
| New | +$289K |
|
|
LABL
4606
DELISTED
Multi-Color Corp
LABL
| $272K | ﹤0.01% |
7,346
+49
| +0.7% | +$1.76K |
|
|
XCO
4607
DELISTED
Exco Resources
XCO
| $272K | ﹤0.01% |
3,617
-6,519
| -64% | -$556K |
|
4608
CALL
Brinker International
EAT
$9.66B
| $271K | ﹤0.01% |
5,900
+2,500
| +74% | +$111K |
|
|
ALOG
4609
DELISTED
Analogic Corp
ALOG
| $271K | ﹤0.01% |
3,068
-5,520
| -64% | -$502K |
|
|
ARI
4610
Apollo Commercial Real Estate
ARI
$885M
| $270K | ﹤0.01% |
16,867
+13,362
| +381% | +$217K |
|
4611
CALL
Banco Bradesco
BBD
$36.7B
| $270K | ﹤0.01% |
57,322
-32,909
| -36% | -$175K |
|
4612
CALL
Cabot Corp
CBT
$4.52B
| $270K | ﹤0.01% |
5,300
+1,900
| +56% | +$89.9K |
|
4613
CALL
Papa John's
PZZA
$806M
| $270K | ﹤0.01% |
6,000
+5,800
| +2,900% | +$232K |
|
|
ALBO
4614
CALL
DELISTED
Albireo Pharma Inc
ALBO
| $270K | ﹤0.01% |
4,500
-8,333
| -65% | -$611K |
|
|
XEC
4615
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $270K | ﹤0.01% |
2,600
-4,500
| -63% | -$456K |
|
|
SQNM
4616
PUT
DELISTED
SEQUENOM INC NEW
SQNM
| $270K | ﹤0.01% |
135,300
+1,700
| +1% | +$4.03K |
|
|
CEB
4617
DELISTED
CEB Inc.
CEB
| $269K | ﹤0.01% |
3,490
-3,094
| -47% | -$228K |
|
4618
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $268K | ﹤0.01% |
4,836
| – | – |
|
|
PCF
4619
High Income Securities Fund
PCF
$99.9M
| $268K | ﹤0.01% |
33,450
+13,848
| +71% | +$113K |
|
|
SPPI
4620
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $268K | ﹤0.01% |
33,500
-9,300
| -22% | -$83.1K |
|
|
HNR
4621
CALL
DELISTED
Harvest Natural Resources
HNR
| $268K | ﹤0.01% |
16,750
+1,500
| +10% | +$26.8K |
|
|
JAH
4622
CALL
DELISTED
JARDEN CORPORATION
JAH
| $268K | ﹤0.01% |
6,600
-25,875
| -80% | -$939K |
|
|
FXEN
4623
DELISTED
FX ENERGY INC
FXEN
| $268K | ﹤0.01% |
89,495
-42,443
| -32% | -$145K |
|
4624
CALL
EQT Corp
EQT
$32.3B
| $267K | ﹤0.01% |
5,511
-31,413
| -85% | -$1.48M |
|
4625
H.B. Fuller
FUL
$3.28B
| $267K | ﹤0.01% |
5,106
-33,381
| -87% | -$1.63M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.